fludarabine has been researched along with Pancreatic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatla, D; Bleesing, J; Crockett, M; Davies, SM; Filipovich, AH; Hansen, M; Harris, RE; Jodele, S; Jordan, M; Mehta, PA; Shenoy, S; Shoultz, L; Smolarek, T | 1 |
| Escudier, SM; Seymour, JF | 1 |
2 other study(ies) available for fludarabine and Pancreatic Diseases
| Article | Year |
|---|---|
Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome.
Topics: Abnormalities, Multiple; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Child; Child, Preschool; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Male; Melphalan; Pancreatic Diseases; Stem Cell Transplantation; Transplantation Conditioning; Vidarabine | 2008 |
Acute leukemia complicating bone marrow hypoplasia in an adult with Shwachman's syndrome.
Topics: Acute Disease; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Male; Neutropenia; Pancreatic Diseases; Syndrome; Vidarabine | 1993 |